Vitamin E Capsules
DEFINITION
Vitamin E Capsules contain Vitamin E or Vitamin E Preparation, where Vitamin E is a form of alpha tocopherol (C29H50O2) that includes d- or dl-alpha tocopherol (C29H50O2), d- or dl-alpha tocopheryl acetate (C31H52O3), and d- or dl-alpha tocopheryl acid succinate (C33H54O5); and Vitamin E Preparation is a combination of a single form of Vitamin E with one or more inert substances. Vitamin E Capsules contain NLT 95.0% and NMT 120.0% of the labeled amount of vitamin E.
IDENTIFICATION
•  A.
[Note—Use low-actinic glassware. ]
Sample solutions 
Alpha tocopherol:  Solution with nominal concentration of 1 mg/mL in dehydrated alcohol
Alpha tocopheryl acetate:  Transfer 220 mg of d- or dl-alpha tocopheryl acetate from the Capsule contents to a round-bottomed, glass-stoppered, 150-mL flask, and dissolve in 25 mL of dehydrated alcohol. Add 20 mL of dilute sulfuric acid in alcohol (1 in 7), and reflux in an all-glass apparatus for 3 h, protected from sunlight. Cool, transfer to a 200-mL volumetric flask, and add dilute sulfuric acid in alcohol (1 in 72) to volume.
Alpha tocopheryl acid succinate:  [Caution—Wear safety goggles. ] Transfer an amount of Capsule contents, equivalent to 200 mg of alpha tocopherol, to a round-bottomed, glass-stoppered, 250-mL flask, dissolve in 50 mL of dehydrated alcohol, and reflux for 1 min. While the solution is boiling, add, through the condenser, 1 g of potassium hydroxide pellets, one at a time to avoid overheating.
Continue refluxing for 20 min and, without cooling, add 2 mL of hydrochloric acid dropwise through the condenser.
[Note—This technique is essential to prevent oxidative action by air while the sample is in an alkaline medium. ]
Cool, and transfer the contents of the flask to a 500-mL separator, rinsing the flask with 100 mL each of water and of ether, and adding the rinsings to the separator. Shake vigorously, allow the layers to separate, and collect each of the two layers in individual separators. Extract the aqueous layer with two 50-mL portions of ether, and add these extracts to the main ether extract. Wash the combined ether extracts with four 100-mL portions of water, then evaporate the ether solution on a water bath under reduced pressure or in an atmosphere of nitrogen until about 7 or 8 mL remain. Complete the evaporation, removing the last traces of ether without the application of heat. Immediately dissolve the residue in dilute sulfuric acid in alcohol (1 in 72), transfer to a 200-mL volumetric flask, and dilute with dilute sulfuric acid in alcohol (1 in 72) to volume.
Analysis 
Sample:  Use the appropriate Sample solution.
Add 2 mL of nitric acid with swirling to 10 mL of Sample solution, and heat at about 75 for 15 min.
Acceptance criteria:  A bright red or orange color develops.
•  B. Optical Rotation 781
Sample solutions 
Alpha tocopherol:  Dissolve an amount of the sample equivalent to100 mg of alpha tocopherol in 50 mL of ether.
Alpha tocopheryl acetate:  Transfer a volume of Sample solution for Alpha tocopheryl acetate from Identification test A, equivalent to 100 mg of the test article, to a separator, and add 200 mL of water. Extract with ether, first with 75 mL, then with 25 mL; and combine the ether extracts in another separator.
Alpha tocopheryl acid succinate:  Transfer a volume of Sample solution for Alpha tocopheryl acid succinate from Identification test A, equivalent to 100 mg of the test article, to a separator, and add 200 mL of water. Extract with ether, first with 75 mL, then with 25 mL; and combine the ether extracts in another separator.
Analysis 
Sample:  Use the appropriate Sample solution.
To the entire volume of a Sample solution, as prepared above, add 20 mL of a solution (1 in 10) of potassium ferricyanide in sodium hydroxide solution (1 in 125), and shake for 3 min. Wash the ether solution with four 50-mL portions of water, discard the washings, and dry over anhydrous sodium sulfate. Evaporate the dried ether solution on a water bath under reduced pressure or in an atmosphere of nitrogen until 7–8 mL remain, then complete the evaporation, removing the last traces of ether without the application of heat. Immediately dissolve the residue in 5.0 mL of isooctane, and determine the optical rotation using as c the number of g of total tocopherols, determined in the Assay, in each 100 mL of solution used for the test.
Acceptance criteria 
Capsules labeled as containing d-isomers:  NLT +24
Capsules labeled as containing dl-forms:  Show essentially no optical rotation
•  C. The retention time of the major peak for alpha tocopherol of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
ASSAY
•  Alpha Tocopherol
[Note—Use low-actinic glassware. ]
Internal standard solution:  1 mg/mL of hexadecyl hexadecanoate in n-hexane
Standard solution:  1 mg/mL of the USP Alpha Tocopherol RS in the Internal standard solution
System suitability solution:  1 mg/mL each of USP Alpha Tocopherol RS and USP Alpha Tocopheryl Acetate RS in n-hexane
Interference check solution:  1 mg/mL of Vitamin E (d- or dl-alpha tocopherol) in n-hexane
Sample solution:  Weigh NLT 10 Capsules in a tared weighing bottle. With a sharp blade or by other appropriate means, carefully open the Capsules, without loss of the shell material, and transfer the combined Capsule content to a 100-mL beaker. Remove any adhering substance from the emptied Capsules by washing with several small portions of n-hexane. Discard the washings, and allow the empty Capsules to dry in a current of dry air until the odor of n-hexane is no longer perceptible. Weigh the empty Capsules in the original tared weighing bottle, and calculate the average net weight per Capsule. Dissolve a portion of the combined Capsule contents with Internal standard solution to prepare a nominally 1-mg/mL solution of Vitamin E (d- or dl-alpha tocopherol).
Chromatographic system 
Mode:  GC
Detector:  Flame ionization
Column:  4-mm × 2-m borosilicate glass column packed with 2%–5% liquid phase G2 on 80- to 100-mesh support S1AB using either a glass-lined sample introduction system or on-column injection
Temperature 
Column:  245–265 (maintained isothermally)
Injector:  10 higher than the column temperature
Detector:  10 higher than the column temperature
Flow rate:  The flow rate of dry carrier gas is adjusted to obtain a hexadecyl hexadecanoate peak about 18–20 min after sample introduction when a 2% column is used, or 30–32 min when a 5% column is used.
Injection size:  2–5 µL
Interference check 
Sample:  Internal standard solution and Interference check solution
Chromatograph the Interference check solution so that the principal peak exhibits NLT 50% of maximum recorder response. Similarly chromatograph the Internal standard solution. If a peak observed in the Interference check solution has the same retention time as that for hexadecyl hexadecanoate, make any necessary correction for factors of dilution or attenuation, and determine the area due to the interfering component that must be subtracted from the area of the internal standard peak appearing in the Sample solution.
System suitability 
Sample:  System suitability solution
Suitability requirements 
Resolution:  NLT 1.0 between the alpha tocopherol and alpha tocopheryl acetate peaks
Relative standard deviation:  NMT 2.0% for replicate injections
Analysis 
Samples:  Standard solution and Sample solution
Calculate the percentage of the labeled amount of alpha tocopherol in the portion of Capsules taken:
Result = (RU/RS) × (CS/CU) × 100
RU== peak area ratio of alpha tocopherol to the internal standard from the Sample solution
RS== peak area ratio of alpha tocopherol to the internal standard from the Standard solution
CS== concentration of USP Alpha Tocopherol RS in the Standard solution (mg/mL)
CU== nominal concentration of alpha tocopherol in the Sample solution (mg/mL)
Acceptance criteria:  95.0%–120.0% of the labeled amount of vitamin E as d- or dl-alpha tocopherol (C29H50O2)
•  Alpha Tocopheryl Acetate
Proceed as directed in the Assay for Alpha Tocopherol. For the Standard solution and Sample solution, substitute alpha tocopheryl acetate for alpha tocopherol and substitute USP Alpha Tocopheryl Acetate RS for USP Alpha Tocopherol RS.
Acceptance criteria:  95.0%–120.0% of the labeled amount of vitamin E as d- or dl-alpha tocopheryl acetate (C31H52O3)
•  Alpha Tocopheryl Acid Succinate
Proceed as directed in the Assay for Alpha Tocopherol. For the Standard solution and Sample solution, substitute alpha tocopheryl acid succinate for alpha tocopherol and substitute USP Alpha Tocopheryl Acid Succinate RS for USP Alpha Tocopherol RS.
Acceptance criteria:  95.0%–120.0% of vitamin E as d- or dl-alpha tocopheryl acid succinate (C33H54O5)
PERFORMANCE TESTS
•  Disintegration 701
Buffer solution:  Dissolve 2.99 g of sodium acetate and 1.66 mL of glacial acetic acid with water to obtain 1000 mL of solution having a pH of 4.5 ± 0.05.
Medium:  Buffer solution
Time:  45 min
•  Uniformity of Dosage Units 905: Meet the requirements
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in tight containers, and store at room temperature. Protect Capsules containing d- or dl-alpha tocopherol from light.
•  Labeling: Label to indicate the chemical form of Vitamin E present and to indicate whether the d- or the dl-form is present, excluding any different forms that may be introduced as a minor constituent of the vehicle. Designate the quantity of Vitamin E present.
•  USP Reference Standards 11
USP Alpha Tocopherol RS Click to View Structure
USP Alpha Tocopheryl Acetate RS Click to View Structure
USP Alpha Tocopheryl Acid Succinate RS Click to View Structure
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Natalia Davydova
Scientific Liaison
1-301-816-8328
(DS2010) Monographs - Dietary Supplements
701 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
1-301-816-8106
(GCDF2010) General Chapters - Dosage Forms
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 5035
Pharmacopeial Forum: Volume No. 28(6) Page 1889